About
Blog

Home
Blog
Companies
BMS

Latest News & Analysis

Professional-grade financial analysis tools for informed investment decisions.

Product

Features
Pricing

Resources

Blog
Knowledge Base
Community
Market Data

Company

About
Careers
Contact
Partners

Legal

Privacy
Terms
License
Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.

K36 Therapeutics' ASH 2024 data: Targeting MMSET/NSD2 for multiple myeloma treatment.

K36 Therapeutics' KTX-1001 Data Shines at ASH 2024

K36 Therapeutics' ASH 2024 presentation highlights promising data for KTX-1001 in multiple myeloma, impacting market positioning and investment decisions.

BMS Company (BMS) News & Analysis | Monexa | Monexa

BMS Company(BMS)

Information about BMS.